Cardiomyopathy and the dilemma of geometric mitral regurgitation

Current Opinion in Cardiology

Volumn 24, Issue 2, 2009, Pages 179-183

  Mehra, Mandeep R ^a,b   Uber, Patricia A ^a   Benitez, Roberto M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Cardiomyopathy; Heart failure; Ischemic; Mitral regurgitation; Nonischemic; Remodeling

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CARDIOVASCULAR PARAMETERS; DISEASE SEVERITY; EXERCISE; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; ISCHEMIC CARDIOMYOPATHY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TRICUSPID VALVE REGURGITATION;

CARDIOMYOPATHIES; CARDIOVASCULAR SURGICAL PROCEDURES; HUMANS; MITRAL VALVE INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

EID: 62249199800     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3283257a47     Document Type: Review

References (24)

1. Mehra MR, Reyes P, Benitez RM, et al. Surgery for severe mitral regurgitation and left ventricular failure: what do we really know? J Card Fail 2008; 14:145-150. A comprehensive review on the mechanisms, epidemiological characteristics and surgical approaches to functional mitral regurgitation. A clinical algorithm for management is provided in this article.
2. Karagiannis SE, Karatasakis GT, Koutsogiannis N, et al. Increased distance between mitral valve coaptation point and mitral annular plane: significance and correlations in patients with heart failure. Heart 2003; 89:1174-1178.
3. Mehra MR, Griffith BP. Is mitral regurgitation a viable treatment target in heart failure? The plot just thickened. J Am Coll Cardiol 2005; 45:388-390.
4. Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 2005; 112:745-758.
5. Ryan LP, Jackson BM, Parish LM, et al. Mitral valve tenting index for assessment of subvalvular remodeling. Ann Thorac Surg 2007; 84:1243-1249.
6. Zoghbi WA, Enriquez-Sarano M, Foster E, et al., American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16:777-802.
7. Thomas L, Foster E, Hoffman JI, Schiller NB. The mitral regurgitation index: an echocardiographic guide to severity. J Am Coll Cardiol 1999; 33:2016-2022.
8. Sadeghpour A, Abtahi F, Kiavar M, et al. Echocardiographic evaluation of mitral geometry in functional mitral regurgitation. J Cardiothorac Surg 2008; 3:54. An observational study to define valve deformation characteristics correlated with severity of geometric mitral regurgitation.
9. Tibayan FA, Wilson A, Lai DT, et al Tenting volume: three-dimensional assessment of geometric perturbations in functional mitral regurgitation and implications for surgical repair. J Heart Valve Dis 2007; 16:1-7.
10. Yamano T, Nakatani S, Kanzaki H, et al. Exercise-induced changes of functional mitral regurgitation in asymptomatic or mildly symptomatic patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2008; 102:481-485. A small but interesting study defining the worsening of mild mitral regurgitation during bicycle exercise in heart failure. This may explain the disconnect between exercise intolerance and rest pump dysfunction.
11. Mehra MR, Uber PA, Francis GS. Heart failure therapy at a crossroad: are there limits to the neurohormonal model? J Am Coll Cardiol 2003; 41:1606-1610.
12. Nemoto S, Hamawaki M, De Freitas G, Carabello BA. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 2002; 40:149-154.
13. Capomolla S, Febo O, Gnemmi M, et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 2000; 139:596-608.
14. Mehra MR, Greenberg BH. Cardiac resynchronization therapy: caveat medicus! J Am Coll Cardiol 2004; 43:1145-1148.
15. St John Sutton MG, Plappert T, Abraham WT, et al., Hill mitral regurgitation; Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003; 107:1985-1990.
16. Kanzaki H, Bazaz R, Schwartzman D, et al. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol 2004; 44:1619-1625.
17. Lancellotti P, Melon P, Sakalihasan N, et al. Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure. Am J Cardiol 2004; 94:1462-1465.
18. Wu AH, Aaronson KD, Boiling SF, et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005; 45:381-387.
19. Romano MA, Boiling SF. Update on mitral repair in dilated cardiomyopathy. J Card Surg 2004; 19:396-400.
20. De Bonis M, Lapenna E, La Canna G, et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the 'edge-to-edge' technique. Circulation 2005; 112 (Suppl 9):I402-I408.
21. Spoor MT, Geltz A, Bolling SF. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. Circulation 2006; 114 (Suppl 1):I67-I71.
22. Haan CK, Cabral CI, Conetta DA, et al. Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. Ann Thorac Surg 2004; 78:820-825.
23. Kron IL, Green GR, Cope JT. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg 2002; 74:600-601.
24. Feldman T, Glower D. Patient selection for percutaneous mitral valve repair: insight from early clinical trial applications. Nat Clin Pract Cardiovasc Med 2008; 5:84-90. A succinct well constructed review on percutaneous techniques for tackling pathological mitral regurgitation.